Effects of tumor necrosis factor-α inhibitors on lung lesions with rheumatoid arthritis

被引：4
|
作者：
Inoue, KI
Takano, H
Yanagisawa, R
Yoshikawa, T
机构：
[1] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan
[2] Kyoto Prefectural Univ Med, Kyoto, Japan
来源：
CHEST | 2003年 / 124卷 / 01期
关键词：
D O I：
10.1016/S0012-3692(15)36047-5
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：413 / 414
页数：2
相关论文
共 50 条
  • [41] The safety of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis
    Victoria Hernandez, Maria
    Sanmarti, Raimon
    Canete, Juan D.
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (05) : 613 - 624
  • [42] Predictors of tumor necrosis factor inhibitors primary failure in rheumatoid arthritis patients
    Khafagi, Amira Mohamed
    Mosa, Doaa Mosad
    Hawaas, Salah
    Hafez, Eman Abdelrazek
    EGYPTIAN RHEUMATOLOGY AND REHABILITATION, 2024, 51 (01)
  • [43] ADHERENCE EVALUATIONS FOR TUMOR NECROSIS FACTOR ALPHA INHIBITORS FOR RHEUMATOID ARTHRITIS I
    Watanabe, J. H.
    Saseen, J. J.
    Dilokthomsakul, P.
    Campbell, J. D.
    VALUE IN HEALTH, 2017, 20 (05) : A148 - A148
  • [44] Longterm Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis
    Emery, Paul
    Vlahos, Bonnie
    Szczypa, Piotr
    Thakur, Mazhar
    Jones, Heather E.
    Woolcott, John
    Estrella, Paul V. Santos
    Rolland, Catherine
    Gibofsky, Allan
    Citera, Gustavo
    Sockalingam, Sargunan
    Marshall, Lisa
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (04) : 493 - 501
  • [45] Validation of a bioassay for predicting response to tumor necrosis factor inhibitors in rheumatoid arthritis
    Ho, Ching-Huang
    Silva, Andrea A.
    Giles, Jon T.
    Bathon, Joan M.
    Solomon, Daniel H.
    Liao, Katherine P.
    Ho, I-Cheng
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (06) : 1086 - 1087
  • [46] Monoamine oxidase inhibitors in rheumatoid arthritis - anti-tumor necrosis factor?
    Altschuler, EL
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 2000, 22 (11): : 1007 - 1008
  • [47] Tumor necrosis factor-α in peripheral nerve lesions
    N. Oka
    I. Akiguchi
    T. Kawasaki
    K. Mizutani
    H. Satoi
    J. Kimura
    Acta Neuropathologica, 1997, 95 : 57 - 62
  • [48] Disease Activity Improvement in Rheumatoid Arthritis Treated with Tumor Necrosis Factor-α Inhibitors Correlates with Increased Soluble Fas Levels
    Romano, Eloisa
    Terenzi, Riccardo
    Manetti, Mirko
    Peruzzi, Francesca
    Fiori, Ginevra
    Nacci, Francesca
    Bellando-Randone, Silvia
    Matucci-Cerinic, Marco
    Guiducci, Serena
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (10) : 1961 - 1965
  • [49] Low rates of adherence for tumor necrosis factor-α inhibitors in Crohn's disease and rheumatoid arthritis: Results of a systematic review
    Herma H Fidder
    Maartje MJ Singendonk
    Mike van der Have
    Bas Oldenburg
    Martijn GH van Oijen
    World Journal of Gastroenterology, 2013, (27) : 4344 - 4350
  • [50] Low rates of adherence for tumor necrosis factor-α inhibitors in Crohn's disease and rheumatoid arthritis: Results of a systematic review
    Fidder, Herma H.
    Singendonk, Maartje M. J.
    van der Have, Mike
    Oldenburg, Bas
    van Oijen, Martijn G. H.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (27) : 4344 - 4350
12345